PTN: Summary for PALATIN TECH INC - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Tuesday, November 24, 2009, 3:25am EST - Canadian Markets open in 6 hours and 5 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Palatin Technologies Inc. (PTN)

On Nov 23: 0.265 USD 0.00 (0.00%)

MORE ON PTN

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

PALATIN TECH INC (AMEX:PTN) Delayed quote data

Last Trade:	0.265 USD
Trade Time:	Nov 23
Change:	0.00 (0.00%)
Prev Close:	0.265
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	1.00

Day's Range:	N/A - N/A
52wk Range:	0.06 - 0.48
Volume:	0
Avg Vol (3m):	914,375
Market Cap:	25.49M
P/E (ttm):	N/A
EPS (ttm):	-0.006
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add PTN to Portfolio

Download Data

HEADLINES

•	PALATIN TECHNOLOGIES INC Financials
	EDGAR Online Financials (Thu, Nov 19)

•	Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
	at Seeking Alpha (Mon, Nov 16)

•	Palatin Technologies Earnings Call scheduled for 11:00 am ET today
	CCBN (Mon, Nov 16)

•	PALATIN TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition
	EDGAR Online (Mon, Nov 16)

•	Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on November 16, 2009
	PRNewswire (Mon, Nov 16)

•	Q1 2010 Palatin Technologies Earnings Release - 07:30 am ET
	CCBN (Mon, Nov 16)

•	PALATIN TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Nov 13)

•	Palatin Technologies, Inc. To Report Fiscal Year 2010 First Quarter Results; Teleconference and Webcast to be held on November 16, 2009
	PRNewswire (Thu, Nov 12)

•	Palatin Technologies to Present at 8th Annual BIO Investor Forum
	PRNewswire (Wed, Oct 28)

•	PALATIN TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement
	EDGAR Online (Tue, Sep 29)

More Headlines for PTN...

ANALYST

EPS Est (next year) (Jun-09) :	N/A
EPS Est (in 2 years) (Jun-10) :	N/A
Avg Rec (current)*:	2.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Palatin Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of peptide, peptide mimetic, and small molecule agonist compounds with a focus on melanocortin (MC) and natriuretic peptide receptor systems in the U...

Full Company Profile

Add to Portfolio

Email to a Friend

•